Trials / Completed
CompletedNCT05032833
Single Ascending Dose Study With 5-MeO-DMT in Healthy Subjects
A Double-Blind, Randomized, Phase 1, First-in-Human, Single Ascending Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetic Profile of Intranasal 5-Methoxy-N,N-dimethyltryptamine (5-MeO-DMT) in Healthy Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 36 (actual)
- Sponsor
- Beckley Psytech Limited · Industry
- Sex
- All
- Age
- 25 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
The study will evaluate safety, tolerability and PK profile of 5-MeO-DMT in healthy subjects
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | 5-MeO-DMT | A single dose of 5-MeO-DMT will be administered intranasally |
| OTHER | Placebo | A single dose of placebo will be administered intranasally |
Timeline
- Start date
- 2021-09-22
- Primary completion
- 2022-07-07
- Completion
- 2022-07-07
- First posted
- 2021-09-02
- Last updated
- 2022-10-12
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT05032833. Inclusion in this directory is not an endorsement.